Impact of mRNA chemistry and manufacturing process on innate immune activation

Nelson, Jennifer, Sorensen, Elizabeth W., Mintri, Shrutika, Rabideau, Amy E., Zheng, Wei, Besin, Gilles, Khatwani, Nikhil, Su, Stephen V. +5 more·2020·Science Advances

Cited by (353)

Items 201–300 of 353

  1. Innovative nonviral gene delivery strategies for engineering human mesenchymal stem cell phenotypes toward clinical applications
    Andrew Hamann, Angela K. Pannier · 2022 · Current Opinion in Biotechnology
  2. Cancer nanotechnology: a new approach to upgrade cancer diagnosis and therapy
    Dorsa Morshedi Rad, Hojjatollah Nazari, Vahid Yaghoubi Naei, Malihe Lotfi, Amir Reza Aref, Majid Ebrahimi Warkiani · 2024 · Elsevier eBooks
  3. Intestinal helminth infection impairs vaccine-induced T cell responses and protection against SARS-CoV-2 in mice
    Pritesh Desai, Courtney E. Karl, Baoling Ying, Chieh-Yu Liang, Tamara García‐Salum, Ana Carolina Santana, Felipe ten-Caten, Joseph F. Urban, Sayda M. Elbashir, Darin K. Edwards et al. · 2024 · Science Translational Medicine
  4. Lipid-Encapsulated mRNAs Encoding Complex Fusion Proteins Potentiate Antitumor Immune Responses
    Casey W. Shuptrine, Yuhui Chen, Jayalakshmi Miriyala, Karen L. Lenz, Danielle Moffett, Thuy‐Ai Nguyen, Jenn Michaux, Kristen Campbell, Connor Smith, Marc Morra et al. · 2024 · Cancer Research
  5. A systemic evaluation of the effect of dsRNA contamination on mRNA vaccine expression and immunogenicity
    Sohee Jo, Ji Sun Lee, Sang‐In Park, Yoonseob Kim, Subin Yoon, Seonghyun Lee, Seongje Cho, Youngran Cho, Ayoung Oh, Dahyeon Ha et al. · 2025 · Journal of Controlled Release
  6. Cell Reprogramming and Differentiation Utilizing Messenger RNA for Regenerative Medicine
    Masahito Inagaki · 2023 · Journal of Developmental Biology
  7. Development and Application of Automated Sandwich ELISA for Quantitating Residual dsRNA in mRNA Vaccines
    David A. Holland, Jillian Acevedo‐Skrip, Joshua R. Barton, Rachel Thompson, Amy M. Bowman, Emily A. Dewar, Danielle V. Miller, Kaixi Zhao, Andrew R. Swartz, John W. Loughney · 2024 · Vaccines
  8. Engineered mRNAs With Stable Structures Minimize Double-stranded RNA Formation and Increase Protein Expression
    Qianshan Qin, Huayuan Yan, Weixiang Gao, Ruyin Cao, Guopeng Liu, Xiaojing Zhang, Niangang Wang, Wenjie Zuo, Lei Yuan, Peng Gao et al. · 2024 · Journal of Molecular Biology
  9. Enhanced Epigenetic Modulation via mRNA-Encapsulated Lipid Nanoparticles Enables Targeted Anti-inflammatory Control
    Tahere Mokhtari, Mohammad Nasser Taheri, Sarah Akhlaghi, Armin Aryannejad, Yuda Xiang, Vineet Mahajan, Kamyar Keshavarz F., Amirreza Kiani, Samantha Yang, Samuel T. LoPresti et al. · 2026 · ACS Synthetic Biology
  10. The Atypical Kinase RIOK3 Limits RVFV Propagation and Is Regulated by Alternative Splicing
    Katherine E. Havranek, Luke Adam White, Thomas C. Bisom, Jean-Marc Lanchy, J. Stephen Lodmell · 2021 · Viruses
  11. mRNA therapy restores ureagenesis and corrects glutathione metabolism in argininosuccinic aciduria
    Sonam Gurung, Oskar Vilhelmsson Timmermand, Dany P.B. Perocheau, Ana Luisa Gil-Martínez, Magdalena Minnion, Loukia Touramanidou, Sherry Fang, Martina Messina, Youssef Khalil, Abigail R. Barber et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  12. DNA damage response and neoantigens: A favorable target for triple-negative breast cancer immunotherapy and vaccine development
    Rajasekaran Subbarayan, Dhasarathdev Srinivasan, Ranjith Balakrishnan, Ajeet Kumar, Salman Sadullah Usmani, Nityanand Srivastava · 2024 · International review of cytology
  13. mRNA Vaccines: Design Principles, Mechanisms, and Manufacturing—Insights From COVID‐19 as a Model for Combating Infectious Diseases
    Saeideh Khorshid Sokhangouy, Matine Behzadi, Shokuh Rezaei, Mahsa Farjami, Milad Haghshenas, Yahya Sefidbakht, Sina Mozaffari‐Jovin · 2025 · Biotechnology Journal
  14. Fluorinated Ribonucleocarbohydrate Nanoparticles Allow Ultraefficient mRNA Delivery and Protein Expression in Tumor-Associated Myeloid Cells
    Hyung Shik Kim, Grant Gerald Simpson, Fan Fei, Christopher Garris, Ralph Weissleder · 2025 · Journal of the American Chemical Society
  15. Therapeutic Potential of Lipid Nanoparticle‐Encapsulated CD19‐Targeting mRNAs in Lupus and Rheumatoid Arthritis
    Chipeng Guo, Yingsen Tang, Ling Zeng, Xiaomei You, Siweier Luo, Yufei Du, Le Wang, Liangchun Wang, Jianchuan Wang, Jinjin Chen et al. · 2025 · Advanced Science
  16. RNA sensor response in HeLa cells for transfected mRNAs prepared in vitro by SP6 and HiT7 RNA polymerases: A comparative study
    Siranjeevi Nagaraj, Anna Stankiewicz-Drogoń, Edward Darżynkiewicz, Renata Grzela · 2022 · Frontiers in Bioengineering and Biotechnology
  17. Hematopoietic stem and progenitors cells gene editing: Beyond blood disorders
    Valentina Buffa, José Roberto Alvarez Vargas, Anne H. M. Galy, Simone Spinozzi, Céline J. Rocca · 2023 · Frontiers in Genome Editing
  18. Delivery platforms for broadly neutralizing antibodies
    Lok Raj Joshi, Nicolás M. S. Gálvez, Sukanya Ghosh, David B. Weiner, Alejandro Benjamin Balazs · 2023 · Current Opinion in HIV and AIDS
  19. ACE mRNA (Additional Chimeric Element incorporated IVT mRNA) for Enhancing Protein Expression by Modulating Immunogenicity
    Sora Son, Minsa Park, Jin Kuk Kim, Kyuri Lee · 2024 · Advanced Science
  20. mRNA Vaccine Mitigates SARS-CoV-2 Infections and COVID-19
    Christina M. Kackos, Sherri L. Surman, Bart G. Jones, Robert E. Sealy, Trushar Jeevan, Christopher J.H. Davitt, Sergei Pustylnikov, Tamarand L. Darling, Adrianus C. M. Boon, Julia L. Hurwitz et al. · 2023 · Microbiology Spectrum
  21. Development of SARS-CoV-2 mRNA vaccines encoding spike N-terminal and receptor binding domains
    Guillaume B. E. Stewart-Jones, Sayda M. Elbashir, Kai Wu, Diana Wing Lee, Isabella Renzi, Baoling Ying, Matthew Koch, Caralyn E. Sein, Angela Choi, Bradley M. Whitener et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  22. Expanding the RNA polymerase biocatalyst solution space for mRNA manufacture
    Edward Curry, Svetlana E. Sedelnikova, John B. Rafferty, Martyn E. Hulley, Melinda Pohle, George Muir, Adam J. Brown · 2024 · Biotechnology Journal
  23. Development and Evaluation of the Immunogenic Potential of an Unmodified Nucleoside mRNA Vaccine for Herpes Zoster
    Shun Zhang, Xiaojie Wang, Tongyi Zhao, Chen Yang, Lulu Huang · 2025 · Vaccines
  24. N1-methylpseudouridine mRNA modification enhances efficiency and specificity of gene overexpression by preventing Prkra-mediated global translation repression
    Tong Lü, Aijun Chen, Changjin Li, Kui Li, Sen Wang, Yizhuang Zhang, Boya Yang, Jiasheng Wang, Qianqian Gong, Ang Li et al. · 2025 · Nucleic Acids Research
  25. Towards mRNA therapeutics 2.0
    Kenneth R. Chien, Kylie S. Foo, Nevin Witman · 2026 · Nature Reviews Drug Discovery
  26. The incidence of movement disorder increases with age and contrasts with subtle and limited neuroimaging abnormalities in argininosuccinic aciduria
    Sonam Gurung, Saketh R. Karamched, Dany P.B. Perocheau, Kiran K. Seunarine, Tomas Baldwin, Haya Alrashidi, Loukia Touramanidou, Claire E. Duff, Nour M. Elkhateeb, Karolina M. Stępień et al. · 2023 · Journal of Inherited Metabolic Disease
  27. One-pot ligation of multiple mRNA fragments on dsDNA splint advancing regional modification and translation
    Yunfan Xu, Shuopeng Qi, Gongrui Zhang, Dan Liu, Dejin Xu, Tong Qin, Qin Cheng, Han Chang Kang, Bei Hu, Zhen Huang · 2025 · Nucleic Acids Research
  28. A sequence-specific RNA acetylation catalyst
    Supuni Thalalla Gamage, Shereen A. Howpay Manage, Aldema Sas‐Chen, Ronit Nir, Brett W. Burkhart, Isita Jhulki, Courtney N. Link, Manini S. Penikalapati, Jane E. Jones, Lakshminarayan M. Iyer et al. · 2025 · Nucleic Acids Research
  29. Lipid Nanoparticle mRNA Therapy Improves Survival and Reduces Serum Branched-Chain Amino Acids in Mouse Models of Maple Syrup Urine Disease
    Jenny A. Greig, Matthew Jennis, Aditya P. Dandekar, Joanna K Chorazeczewski, Nesteene Joy Param, Meardey So, Mohamad Nayal, Peter L. Bell, Kimberly A. Coughlan, Minjung Choi et al. · 2024 · Human Gene Therapy
  30. Purification technologies for induced pluripotent stem cell therapies
    Melanie Generali, Yoshihiko Fujita, Debora Kehl, Moe Hirosawa, Maximilian Y. Emmert, JUN C. TAKAHASHI, Simon Philipp Hoerstrup, Hirohide Saito · 2024 · Nature Reviews Bioengineering
  31. Data-informed reparameterization of modified RNA and the effect of explicit water models: application to pseudouridine and derivatives
    Nivedita Dutta, Indrajit Deb, Joanna Sarzyńska, Ansuman Lahiri · 2022 · Journal of Computer-Aided Molecular Design
  32. Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19
    Agustı́n Valenzuela-Fernández, Romina Cabrera-Rodríguez, Laura Ciuffreda, Silvia Pérez-Yanes, Judith Estévez‐Herrera, Rafaela González‐Montelongo, Julia Alcoba-Flórez, Rodrigo Trujillo‐González, Diego García-Martínez de Artola, Helena Gil-Campesino et al. · 2022 · Frontiers in Bioengineering and Biotechnology
  33. Progress in vaccine development for infectious diseases—a Keystone Symposia report
    Jennifer Cable, Barney S. Graham, Richard A. Koup, Robert A. Seder, Katalin Karikó, Norbert Pardi, Dan H. Barouch, Bhawna Sharma, Susanne Rauch, Raffael Nachbagauer et al. · 2023 · Annals of the New York Academy of Sciences
  34. Cancer cells co-evolve with retrotransposons to mitigate viral mimicry
    Siyu Sun, Jungeui Hong, Eunae You, Kaloyan M. Tsanov, Jonathan A. Chacon-Barahona, Andrea Di Gioacchino, David Hoyos, Hao Li, Hua Liang Jiang, Bao-Han Ly et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  35. Development of a capillary zone electrophoresis method to monitor magnesium ion consumption during in vitro transcription for mRNA production
    Ying Wang, Li Li, Adam T. Sutton, Qiang Tu, Kaixi Zhao, Emily P. Wen, James Osborn, Andrew N. Singh, Matthew J. Gunsch, Richard R. Rustandi et al. · 2024 · Analytical and Bioanalytical Chemistry
  36. Research progress on immune mechanism and control strategy of dsRNA impurities in mRNA vaccine
    Xinjun Liu, Chaoying Hu, Qian He, Yu Bai, Xuanxuan Zhang, Zhihao Fu, Xiao Ma, Miao Xu, Zhenglun Liang, Qunying Mao · 2025 · Expert Review of Vaccines
  37. Overcoming antifungal resistance in Candida albicans via RNA interference: a therapeutic perspective
    Akshay Kisan Mundhe, Reena Rajkumari · 2025 · Frontiers in Cellular and Infection Microbiology
  38. Myomerger-derived peptide enhances skeletal muscle tropism and reduces liver transduction of lipid nanoparticles for gene delivery
    Jacqueline Ji, Eva Lipkow, Nicolas Anton, Corinne Crucifix, Pascal Eberling, Jocelyn Laporte · 2025 · Molecular Therapy — Nucleic Acids
  39. Beyond the Sequence: Chemical and Topological Design and Innovations in mRNA Therapeutics
    Dangliang Liu, Hongyu Chen, Alisia Pan, Xiao Wang · 2026 · Chemical Reviews
  40. Ipsilateral or contralateral boosting of mice with mRNA vaccines confers equivalent immunity and protection against a SARS-CoV-2 Omicron strain
    Baoling Ying, Chieh-Yu Liang, Pritesh Desai, Suzanne M. Scheaffer, Sayda M. Elbashir, Darin K. Edwards, Larissa B. Thackray, Michael Diamond · 2024 · Journal of Virology
  41. mRNA-Based Nanomedicine: A New Strategy for Treating Infectious Diseases and Beyond
    Satyendra Prakash · 2023 · European Journal of Drug Metabolism and Pharmacokinetics
  42. Fcγ receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2
    Samantha Mackin, Pritesh Desai, Bradley M. Whitener, Courtney E. Karl, Meizi Liu, Ralph Steven Baric, Darin K. Edwards, Taras M. Chicz, Ryan P. McNamara, Galit Alter et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  43. Therapeutic Prospects of Artificially Synthesized Circular RNA
    Hui Chen, Yi Du, Yesheng Wang, Xue Zhang, Maolei Zhang, Xingguo Liang, Qiyi Zhao, Ming Liu · 2026 · Wiley Interdisciplinary Reviews - RNA
  44. Lipid Nanoparticle–Encapsulated mRNA-2752 Encoding Human OX40L, IL-23, and IL-36γ plus Durvalumab Induces an Immunostimulatory Effect within the Tumor Microenvironment in Patients with Advanced Solid Tumors
    Randy F. Sweis, Georgina Venetia Long, ADIL I. DAUD, Salomon Marcello Stemmer, Antonio Jimeno, Ruth Perets, Shivaani Kummar, Manish R. Patel, Adnan Khattak, Michael Abadier et al. · 2026 · Clinical Cancer Research
  45. A non-lipid nucleic acid delivery vector with dendritic cell tropism and stimulation
    Hyung Shik Kim, Elias A. Halabi, Noah Enbergs, Rainer H. Köhler, Fan Fei, Christopher Garris, Ralph Weissleder · 2024 · Theranostics
  46. Future prospects in mRNA vaccine development
    Londiwe Simphiwe Mbatha, Jude Akinyelu, Fiona Maiyo, Tukayi Kudanga · 2023 · Biomedical Materials
  47. Advances in Isotope Labeling for Solution Nucleic Acid Nuclear Magnetic Resonance Spectroscopy
    Stefan Hilber, Solomon K. Attionu, Theodore Kwaku Dayie, Christoph Kreutz · 2025 · ChemPlusChem
  48. A extrafiscalidade e os controles de proporcionalidade e de igualdade
    Marcel Davidman Papadopol · 2009 · Americanae (AECID Library)
  49. mRNA delivery of dimeric human IgA protects mucosal tissues from bacterial infection
    Cailin E. Deal, Angelene F. Richards, Tracy Yeung, Max J. Maron, Ziqiu Wang, Yen‐Ting Lai, Brian R. Fritz, Sunny Himansu, Elisabeth Narayanan, Ding Liu et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  50. Is immunotherapy a potential game changer in managing human papillomavirus (HPV) infection and intraepithelial neoplasia?
    Peter L. Stern · 2023 · Tumour Virus Research
  51. Evaluating the breadth of nucleic acid-based payloads delivered in lipid nanoparticles to establish fundamental differences in development
    Jinjin Li, Camilla Foged · 2024 · Expert Opinion on Drug Delivery
  52. The multifaceted roles of E3 ubiquitin ligases in osteoarthritis
    Zheng Jin, Zhenhua Zhu, Jun Chen, Xiaopeng Jing, Jie Tan, Ji Zeng · 2025 · Frontiers in Cell and Developmental Biology
  53. Incorporation of monophosphoryl lipid A and CpG-oligodeoxynucleotides into lipid nanoparticles activates toll-like receptor signaling pathways while maintaining antigen expression for mRNA-based vaccinations
    Ana Pena Vaquero, Paula Calderón-Ruiz, Rocío Celeste Gambaro, Ignacio Rivero Berti, M. A. Limeres, Silvia Fraude-El Ghazi, Cristián Huck‐Iriart, Claudius U. Meyer, Maximiliano L. Cacicedo, Thomas Hankeln et al. · 2025 · International Journal of Biological Macromolecules
  54. Incorporating mRNA therapeutics into biological treatments of hematologic malignancies
    Jaromir Hunia, Jaromir Tomasik, Natalia Czerwik, Parmida Sadat Pezeshki, Dominika Nowis · 2025 · Frontiers in Immunology
  55. Deep learning-guided dual-fitness evolution of T7 RNA polymerase for enhanced stability and activity
    Fan Jiang, Liqi Kang, Mingchen Li, Bozitao Zhong, Xiaoxia Chen, Banghao Wu, Mengrong Li, Yuanxi Yu, Liang Hong · 2026 · Nucleic Acids Research
  56. Chemically modified nucleic acid nanodevices: molecular engineering for drug delivery, theranostics, biosensing and diagnostics
    Caini Wang, Shuyao Yang, Ting Wang, Tiancong Wang, Meixia Wang, Zhipeng Su, Jun Zhu, Chun-Hui Zhang, Fang He, Hong-Hui Wang · 2026 · Chemical Communications
  57. Identification of ferroptosis-associated tumor antigens as the potential targets to prevent head and neck squamous cell carcinoma
    Qiming Zhai, Zhiwei Wang, Han Tang, Shanshan Hu, Meihua Chen, Ping Ji · 2024 · Genes & Diseases
  58. Characterization of a novel conditional knockout mouse model to assess efficacy of mRNA therapy in the context of severe OTC deficiency
    Jenny Zhou, Shi Liang, Ling Yin, Andrea Frassetto, Anne-Renee Graham, Rebecca A. White, Maria Principe, Madelyn Severson, Tiffany Palmer, Shan K. Naidu et al. · 2025 · Molecular Therapy
  59. Synthesis of Nucleic Acids
    Jonathan K. Watts, Michael John Gait · 2022 · Royal Society of Chemistry eBooks
  60. Mitigating Cellular Dysfunction by Addressing Contaminants in Synthetic circRNA
    Ziwei Zhang, Weiyu Li, Dengwang Luo, Xiushuang Yuan, Li‐Rong Yu, Daming Wang, Yuhong Cao · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  61. RNA oligomers at atomic resolution containing 1‐methylpseudouridine, an essential building block of mRNA vaccines
    Philipp P. Nievergelt, Florian Berliat, Katherine Evelyn McAuley, Colin R. Dorgan, Renate M. van Well, Andrea Thorn, Bernhard Spingler · 2024 · ChemMedChem
  62. Marginal-zone B cells as promising targets of an mRNA-loaded, lipid-nanoparticle cancer vaccine
    Yuichi Suzuki, Mai Yakuwa, Mina Sato, Eleni Samaridou, Moritz Beck‐Broichsitter, Masatoshi Maeki, Manabu Tokeshi, Yuma Yamada, Hideyoshi Harashima, Yusuke Sato · 2025 · Next Nanotechnology
  63. Graphene Oxide-Modified Resin for Selective dsRNA Removal from In Vitro-Transcribed mRNA
    Junhyung Ryu, Jayoung Namgung, Jinmin Jang, Goeun Lee, Kwanghee Yoo, Bong‐Hyun Jun, Dong‐Eun Kim · 2025 · ACS Applied Bio Materials
  64. Harnessing dendritic cells as immunological bridges to potentiate mRNA cancer vaccines
    Ruiying Wu, Huixin Li, Ziqin Li, Kai Hao, Huayu Tian · 2025 · Journal of Materials Chemistry B
  65. Eine chemo‐enzymatische Modifizierung der 5′‐Kappe erhält die Translation und erhöht die Immunogenität der mRNA
    Melissa van Dülmen, Nils Muthmann, Andrea Rentmeister · 2021 · Angewandte Chemie
  66. Deconvolution of synthetic mRNA expression: Nucleoside chemistry alters translatability
    Hanieh Moradian, Marko Schwestka, Toralf Roch, Manfred Gossen · 2023 · Bioengineering & Translational Medicine
  67. Nebulization of an mRNA-encoded monoclonal antibody for passive immunization of foals against Rhodococcus equi
    Rebecca M. Legere, Jeannine A. Ott, Cristina Poveda, Daryll A. Vanover, Karin E. R. Borba, Jae Yeon Joo, Cameron Lee Martin, Bibiana Petri da Silveira, Jocelyne M. Bray, Kerstin K. Landrock et al. · 2025 · Molecular Therapy
  68. A Historical Overview on mRNA Vaccine Development
    Rein Verbeke, Miffy H. Y. Cheng, Pieter R. Cullis · 2024 · Wiley eBooks
  69. Reprogramming Glutamine Metabolism of Dendritic Cells Boosts Lymph Nodes Migration and Tumor Immunotherapy
    Yi Pan, Lulu Jin, Yang Huang, Danfeng Jian, Курлович Иван Васильевич, Maksim Beluga, A.S. STALYBKA, Xiaozhou Mou, Yang Zhu, Zhengwei Mao et al. · 2025 · Advanced Functional Materials
  70. Systemically delivered lipid nanoparticle-mRNA encoding lysosomal acid β-glucosidase restores the enzyme deficiency in a murine Gaucher disease model
    Yuanqing Liu, Shasha Wang, Yanni Chen, Zhang Zhang, Xiao‐Jiang Quan, Zhijun Guo, Zihao Wang · 2025 · Gene Therapy
  71. Localized 2′-OH Acylation at Poly(A) Extends RNA Translation
    Linglan Fang, Wenrui Zhong, Lu Xiao, Ryuta Shioi, Allan Lee, Charlotte H. Bravo, Eric T. Kool · 2025 · Journal of the American Chemical Society
  72. Harnessing mRNA for the expression of monoclonal IgG and IgA in non-human primates
    Romy Rouzeau, Hayden R. Schmidt, Cailin E. Deal, Joel D. Allen, Dawn M. Dudley, Iszac Burton, Eva G. Rakasz, Obadiah J. Plante, Max Crispin, Andrea Carfı́ et al. · 2026 · Frontiers in Immunology
  73. Recent advances in LNP-mRNA vaccines
    Benjamin J. Redenti, Yichen Zhong, Changyue Yu, Yizhou Dong · 2026 · Colloids and Surfaces B Biointerfaces
  74. A comprehensive analysis of the use of nucleoside analogues in RNA therapeutics
    Kukushkina-Zvezdova, Alisa A., Zherebtsova, Anna A., Telegina, Darya V., Skvortsov, Ivan A., Ivanov, Roman A., Reshetnikov, Vasiliy V. · 2026 · Journal of Translational Medicine
  75. Combination adjuvants: clinical value and mechanisms of action
    Natacha Madelon, Arnaud M. Didierlaurent · 2026 · Current Opinion in Virology
  76. Engineered circular RNA compatible with complete nucleoside modification and rolling circle translation through a Cap-independent translation enhancer
    Xinyue Wang, Qian Pan, Jie Yin, Haomeng Kou, Xinyuan Liao, Chi Zhang, Yanyan Wang, Shengnan She, Ligaoyue Zhang, Wanjia Wang et al. · 2026 · Nature Biomedical Engineering
  77. Preparation of Messenger RNA-Loaded Nanomedicine Applied on Tissue Engineering and Regenerative Medicine
    Hsi‐Kai Tsou, Cheng-Chung Chang, Tomoji Maeda, Chin‐Yu Lin · 2022 · RNA technologies
  78. mRNA Vaccines: Immunology and Present and Future Potential
    Omar F. Khan, Julien Couture‐Senécal, Yan Ming Anson Lau, Ana-Maria Oproescu, Janice Pang, Grayson Tilstra, Brianna A. Walz · 2024 · Springer eBooks
  79. Antitumor mRNA vaccines based on neoantigens
    Ekaterina V. Starostina, L. F. Nizolenko, Л. И. Карпенко, A. A. Ilyichev · 2025 · Siberian Journal of Oncology
  80. RNA therapies hold great promise for treating cancer. High-throughput screening techniques have facilitated the development of RNA treatments
    Moataz Dowaidar · 2021
  81. Functional mRNA delivery to hematopoietic stem and progenitor cells in vivo
    David Álvarez, Guillemette Masse‐Ranson, Saikiran K. Sedimbi, Phylicia Wisti, Lisa Rodriguez, Jordan Santana, Taylor Manning, Tim Towner, Benjamin Geilich, Cosmin Mihai et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  82. Neoantigen mRNA Cancer Vaccines: How Deep Learning Is Advancing Design and Breaking Barriers
    Saba Ismail, Khaled Barakat · 2025 · IntechOpen eBooks
  83. Template nicking suppresses promoter-independent antisense transcription in IVT via R-loop-mediated strand displacement
    Goeun Lee, Junhyung Ryu, Jinmin Jang, Wooseong Noh, Dong-Eun Kim · 2026 · Nucleic Acids Research
  84. ShortCut RNase III is capable of digesting single mRNA transcripts into < 10 nucleotide products
    Kyle J. Tynan, Mark S. Lowenthal, Karndeep Singh, Trina Mouchahoir, Daniel Hunter, Karen W. Phinney · 2026 · Biochimie
  85. N1MΨU-modified mRNA vaccines break the mold in fish by enhancing innate immune activation
    Dean Porter, Luc Jouneau, Mathilde Peruzzi, Bertrand Collet, Bernard Verrier, Pierre Boudinot · 2026 · Molecular Therapy — Nucleic Acids
  86. Maternal expression and breast milk transfer of an mRNA- encoded monoclonal antibody in a murine model of cholera
    Jennifer Doering, Yetunde Adewunmi, Cailin E. Deal, Obadiah J. Plante, Andrea Carfı́, Nicholas John Mantis · 2026 · PLoS neglected tropical diseases
  87. Decoding Self vs. Non-Self: Alphavirus Cap0 Recognition and Immune Evasion
    Santiago Enrique Faraj, Claudia V. Filomatori · 2026 · Viruses
  88. Efficacy and Safety of Messenger RNA Vaccines
    Kesaobaka Batisani, David Chisompola · 2026 · Health Science Reports
  89. Unlocking translational resilience for mRNA vaccines by viral UTRs
    Jordan James Minnell, Jochem N. A. Vink, Rebecca E. McKenzie · 2026 · Molecular Therapy — Nucleic Acids
  90. Innate immune responses underlying local and systemic adverse reactions to mRNA–lipid nanoparticle vaccines
    Tomohiro Takano, Takayuki Matsumura, Yoshimasa Takahashi · 2026 · International Immunology
  91. Adjuvants, the Elephant in the Room for RNA Vaccines
    Sigrid D’haese, Sabine den Roover, Joeri L. Aerts · 2022 · RNA technologies
  92. pDNA and mRNA vaccines
    Kanwal Gill, Leanne Minall, Aslin Rodríguez Nassif · 2021 · Elsevier eBooks
  93. Targeted enzyme assisted chemotherapy (TEAC) – a novel microRNA-guided and selenium-based regimen to specifically eradicate hepatocellular carcinoma
    Arun Kumar Selvam, Rim Jawad Wiklander, Roberto Gramignoli, Adnane Achour, Hugh Salter, Mikael Björnstedt · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  94. IL-1β and IL-1ra are key regulators of the inflammatory response to RNA vaccines
    Ira Mellman, Siri Tähtinen, Ann-Jay Tong, Patricia Himmels, Jaehak Oh, Andrés Paler-Martı́nez, Leesun Kim, Sara M. Wichner, Yoko A. Oei, Mark J. McCarron et al. · 2021 · Research Square
  95. Ex vivo primary liver sections recapitulate disease phenotype and therapeutic rescue for liver monogenic diseases
    Dany P.B. Perocheau, Sonam Gurung, Loukia Touramanidou, Claire E. Duff, Garima Sharma, Neil James Sebire, Patrick F. Finn, Alex Cavedon, Summar Siddiqui, Lisa M. Rice et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  96. Circulating Synthetic SARS-CoV-2 Spike Proteins Possibly Contribute to a Transient ACE2 Dysfunction Leading to Rare Cases of Myocarditis after COVID-19 mRNA Vaccination
    Christian Albert Devaux, Philippe Colson, Didier Raoult, Laurence Camoin‐Jau · 2023 · Preprints.org
  97. Intestinal helminth infection impairs vaccine-induced T cell responses and protection against SARS-CoV-2
    Pritesh Desai, Courtney E. Karl, Baoling Ying, Chieh-Yu Liang, Tamara García‐Salum, Ana Carolina Santana, Felipe ten-Caten, Joseph F. Urban, Sayda M. Elbashir, Darin K. Edwards et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  98. Modified or Unmodified mRNA Vaccines? – The Biochemistry of Pseudouridine and mRNA Pseudouridylation
    Pedro Morais, Yi‐Tao Yu · 2024 · Wiley eBooks
  99. ZUGC-RNA degradation generates immunosuppressor to evade immune responses in eukaryotes
    Shuliang Gao, Mengting Chen, Douglas Wich, Hanan Bloomer, Zhiyuan Qu, Huiwen Guan, Qiaobing Xu · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  100. dsRADAR: Imaging and Quantifying Cellular dsRNA by Repurposing RNA Binding Proteins
    Weina Cheng, Tyson D. Todd, Harshad Ingle, Angela M. Halstead, Megan T. Baldridge, José B. Sáenz, Jennifer M. Heemstra · 2026 · bioRxiv (Cold Spring Harbor Laboratory)